Related Experiment Videos
Lymphoproliferative lesions in BB Wistar rats.
Metabolism: Clinical and Experimental
|July 1, 1983
Summary
Diabetic BB Wistar rats showed an increased incidence of B cell lymphoproliferative lesions and lymph node abnormalities. These findings suggest altered immunity in this diabetes model.
Area of Science:
- Immunology
- Pathology
- Endocrinology
Background:
- The BB Wistar rat is a key model for studying Type 1 diabetes.
- Altered immune function is implicated in the pathogenesis of diabetes.
- Lymphoproliferative disorders can be associated with immune dysregulation.
Purpose of the Study:
- To investigate the occurrence and morphology of lymphoproliferative lesions in diabetic BB Wistar rats.
- To examine lymph node abnormalities in both diabetic and nondiabetic BB Wistar rats.
- To assess the implications of these findings for immune alterations in this model.
Main Methods:
- Histopathological examination of abdominal lymphoid tissues and lymph nodes from diabetic and nondiabetic BB Wistar rats.
- Morphological classification of observed lesions, including B cell lymphoproliferative disorders and lymphomas.
Main Results:
- Fifteen percent of long-term diabetic BB Wistar rats developed abdominal B cell lymphoproliferative lesions.
- Lesions ranged from benign aggregates to malignant lymphomas (immunoblastic sarcoma, plasma-cell lymphoma).
- Both diabetic and nondiabetic rats exhibited variable, often extensive, lymph node replacement by plasmacytoid lymphocytes and plasma cells.
Conclusions:
- Diabetic BB Wistar rats exhibit a higher incidence of B cell lymphoproliferative lesions.
- Morphological abnormalities in lymph nodes are present in this model, irrespective of diabetic status.
- These findings provide further evidence of altered immunity in the BB Wistar rat model of diabetes.